In brief, we uncovered an unanticipated ablation of the Notch1‐p15‐mediated tumor suppression by ANXA1 in AML through the ubiquitination‐proteasome degradation of NICD to block the transcriptional activation of p15 in vitro and in vivo. The gene discussed is CDKN2B; the disease is acute myeloid leukemia.